Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668731 | SCV000793379 | likely pathogenic | Ellis-van Creveld syndrome | 2017-08-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001042997 | SCV001206707 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp828*) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Ellis–van Creveld syndrome (PMID: 23026208). ClinVar contains an entry for this variant (Variation ID: 553315). For these reasons, this variant has been classified as Pathogenic. |